• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ensysce Biosciences Inc (NQ: ENSC )

    0.3222 -0.0081 (-2.45%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 191,509
    Open 0.3321
    Bid (Size) 0.3200 (30)
    Ask (Size) 0.3220 (4)
    Prev. Close 0.3303
    Today's Range 0.3200 - 0.3350
    52wk Range 0.3130 - 2.060
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ensysce Biosciences Submits Phase 3 Protocol to the FDA
    Via ACCESSWIRE
    Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024
    Via ACCESSWIRE

    Performance

    YTD
    -70.97%
    -70.97%
    1 Month
    -20.93%
    -20.93%
    3 Month
    -40.93%
    -40.93%
    6 Month
    -58.75%
    -58.75%
    1 Year
    -80.71%
    -80.71%

    More News

    Read More
    Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
    Via Benzinga
    Topics Earnings
    Exposures Financial Fossil Fuels
    Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
    Via Benzinga
    Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
    Via Benzinga
    Dow Jumps Over 100 Points; Nvidia Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Ensysce Biosciences Announces IRB Approval for Key MPAR Study
    Via ACCESSWIRE
    Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
    Via ACCESSWIRE
    Ensysce Biosciences Provides Mid-Year 2024 Update
    Via ACCESSWIRE
    Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants
    Via ACCESSWIRE
    Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    S&P 500 Edges Higher; American Woodmark Shares Slide
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
    Via ACCESSWIRE
    Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
    Via ACCESSWIRE
    Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
    Via ACCESSWIRE
    Crude Oil Dips; Addex Therapeutics Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    US Stocks Mixed; ScanSource Reports Weak Q4 Results
    Via Benzinga
    ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Ensysce Biosciences Reports Second Quarter 2024 Financial Results
    Via ACCESSWIRE
    ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
    Via ACCESSWIRE
    Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.